KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Receivables Refunds (2019 - 2021)

Historic Receivables Refunds for Travere Therapeutics (TVTX) over the last 3 years, with Q4 2021 value amounting to $247000.0.

  • Travere Therapeutics' Receivables Refunds fell 9855.91% to $247000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $247000.0, marking a year-over-year decrease of 9855.91%. This contributed to the annual value of $247000.0 for FY2021, which is 9855.91% down from last year.
  • Travere Therapeutics' Receivables Refunds amounted to $247000.0 in Q4 2021, which was down 9855.91% from $405000.0 recorded in Q3 2021.
  • Travere Therapeutics' Receivables Refunds' 5-year high stood at $20.2 million during Q1 2020, with a 5-year trough of $247000.0 in Q4 2021.
  • Its 3-year average for Receivables Refunds is $10.1 million, with a median of $13.6 million in 2020.
  • In the last 5 years, Travere Therapeutics' Receivables Refunds soared by 112881.72% in 2020 and then tumbled by 9855.91% in 2021.
  • Quarter analysis of 3 years shows Travere Therapeutics' Receivables Refunds stood at $1.4 million in 2019, then skyrocketed by 1128.82% to $17.1 million in 2020, then plummeted by 98.56% to $247000.0 in 2021.
  • Its Receivables Refunds was $247000.0 in Q4 2021, compared to $405000.0 in Q3 2021 and $400000.0 in Q2 2021.